RxSight (RXST) Gains from Investment Securities (2020 - 2021)
RxSight's (RXST) quarterly Gains from Investment Securities came in at $5.4 million in Q4 2021, up 115.49% YoY from $2.5 million in Q4 2020, and up 461.54% on a QoQ basis from -$1.5 million in Q3 2021.
RxSight (RXST) Gains from Investment Securities (2020 - 2021) Analysis & Trends
RxSight (RXST) has 2 years of Gains from Investment Securities data on file, last reported at $5.4 million in Q4 2021.
- Quarterly Gains from Investment Securities rose 115.49% year-over-year to $5.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $5.4 million (up 116.79% YoY) and the FY2025 annual result came in at $1.5 million, up 113.74% from the prior year.
- Gains from Investment Securities grew to $5.4 million in Q4 2021, from -$1.5 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.4 million in Q4 2021 to a low of -$39.5 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | RxSight | 259.94 Mn | -144.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.43 Mn |
| Dec 31, 2021 | 5.43 Mn |
| Sep 30, 2021 | -1.50 Mn |
| Sep 30, 2021 | -1.50 Mn |
| Jun 30, 2021 | -1.21 Mn |
| Jun 30, 2021 | -1.21 Mn |
| Dec 31, 2020 | -35.08 Mn |
| Dec 31, 2020 | -35.08 Mn |
| Sep 30, 2020 | -39.52 Mn |
| Sep 30, 2020 | -39.52 Mn |
| Jun 30, 2020 | 4.18 Mn |
| Jun 30, 2020 | 4.18 Mn |